Assembly Biosciences (ASMB)
NASDAQ:ASMB
Holding ASMB?
Track your performance easily

Assembly Biosciences (ASMB) Financial Statements

536 Followers

Assembly Biosciences Financial Overview

Assembly Biosciences's market cap is currently ―. The company's EPS TTM is $-7.144; its P/E ratio is -2.35; Assembly Biosciences is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-2.07. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 8.53M$ 5.79M---
Gross Profit$ 8.53M$ 5.79M---
EBIT$ -12.20M$ -10.73M$ -15.05M$ -17.49M$ -18.95M
EBITDA$ -12.17M$ -10.70M$ -14.93M$ -17.36M$ -18.88M
Net Income Common Stockholders$ -11.15M$ -9.08M$ -14.42M$ -16.90M$ -18.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 109.22M$ 112.98M$ 46.21M$ 59.83M$ 73.02M
Total Assets$ 115.32M$ 119.88M$ 51.63M$ 66.58M$ 83.12M
Total Debt$ 1.75M$ 1.94M$ 919.00K$ 1.77M$ 2.63M
Net Debt$ -107.47M$ -111.04M$ -45.29M$ -58.06M$ -70.39M
Total Liabilities$ 80.64M$ 87.28M$ 9.91M$ 11.63M$ 12.78M
Stockholders Equity$ 34.68M$ 32.60M$ 41.71M$ 54.95M$ 70.33M
Cash Flow-
Free Cash Flow$ -17.12M$ -18.38M$ -13.98M$ -13.68M$ -23.43M
Operating Cash Flow$ -17.10M$ -18.36M$ -13.85M$ -13.63M$ -23.43M
Investing Cash Flow$ 5.11M$ 17.27M$ 18.88M$ -8.37M$ 10.00M
Financing Cash Flow$ 12.45M--$ 134.00K$ 4.49M
Currency in USD

Assembly Biosciences Earnings and Revenue History

Assembly Biosciences Debt to Assets

Assembly Biosciences Cash Flow

Assembly Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis